BREAKING: FDA Authorizes COVID-19 Shots For Kids Under Five Years Old
On Friday, the Food and Drug Administration (FDA) authorized the first COVID-19 shots for infants and preschoolers. Meaning U.S. kids under five years old are eligible for vaccinations. All that is left is a final signoff from Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky.
The move came after the FDA’s advisory panel’s unanimous recommendation for the shots from Moderna and Pfizer. Which is expected to impact around 18 million children across the nation.
Vaccinations could begin as early as Monday or Tuesday.
Though these vaccinations were originally intended for those hit hardest during the pandemic – U.S. adults. School-aged children and teens are now being recommended the shots, with some school districts and universities still requiring the vaccination for enrollment.
Walensky made it clear during a Senate hearing on Thursday that this push was a top priority for the organization. She even went on to state that her staff would be working over the Juneteenth federal holiday “because we understand the urgency of this for American parents.”
“So I actually think we need to protect young children, as well as protect everyone with the vaccine and especially protect elders,” she added, referencing that pediatric deaths from COVID-19 have been higher than what is normally seen from the flu each year.
As many Americans have pointed out, young children do not typically face risks from COVID-19 compared to adults. They have also highlighted the various side effects that often get ignored by the corporate press and big tech like fevers and fatigue.
Regardless, the FDA believes the benefits of these vaccinations outweigh any side effects. It also argues that vaccinations for kids under five years old are something the typical American family has been waiting and hoping for to ensure safety in classrooms.
“As COVID-19 can cause severe illness in children, some of whom do not currently have a vaccination option, there continues to be a need for safe and effective COVID-19 treatment options for this population,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. “Today’s approval of the first COVID-19 therapeutic for this population demonstrates the agency’s commitment to that need.”
As the FDA and CDC continue to sign off on more vaccines, their focus is now becoming more apparent; getting as many people vaccinated as possible – regardless of age. This latest move will likely be a controversial one. Which will surely spark outrage amongst American families who do not want to see vaccine madidates for children 5 and younger in the future.